GLP-1 Drug Users Show Reduced Risk of Disease After Weight Loss, Study Reports
Obesity currently affects more than 40 per cent of adults. This condition drives high rates of heart disease and…
-
-
Novo Nordisk and Eli Lilly Weight-Loss Pill Performance
Novo Nordisk recently announced that its oral semaglutide pill achieved superior weight loss results. This data comes from late-stage…
